Healthcare & Life Sciences

SpheroTec GmbH

Germany
Sign in to unlock

About

SpheroTec GmbH develops technology to create three-dimensional microtumors (spheroids) from patient tissue samples that closely replicate the original tumor, enabling testing of cancer drugs and drug combinations ex vivo to inform personalized treatment decisions.

Explore SpheroTec GmbH's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing